Dow Up0.05% Nasdaq Down0.18%

Myriad Genetics, Inc. (MYGN)

-NasdaqGS
34.19 Up 0.25(0.74%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Total Revenue 193,300   183,500   189,884   180,016  
Cost of Revenue40,600  36,500  38,389  36,311  
Gross Profit 152,700   147,000   151,495   143,705  
Operating Expenses
Research Development16,700  17,200  18,712  16,688  
Selling General and Administrative90,800  86,500  96,585  91,315  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 45,200   43,300   36,198   35,702  
Income from Continuing Operations
Total Other Income/Expenses Net(100)200  (682)(118)
Earnings Before Interest And Taxes45,100  43,500  35,516  35,584  
Interest Expense -   -   -   -  
Income Before Tax45,100  43,500  35,516  35,584  
Income Tax Expense14,700  16,900  16,804  14,096  
Minority Interest -   -   -   -  
Net Income From Continuing Ops30,400  26,600  18,712  21,488  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 30,400   26,600   18,712   21,488  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 30,400   26,600   18,712   21,488  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.